| Mrs Stephanie Marie Sumner, APRN, FNP-C | |
|
100 London Mountain View Dr Fl 1, London, KY 40741-6668 | |
| (859) 275-5229 | |
| (859) 977-2683 |
| Full Name | Mrs Stephanie Marie Sumner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 100 London Mountain View Dr Fl 1, London, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013550060 | NPI | - | NPPES |
| 7100635060 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3013971 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Cumberland Regional Hospital | Somerset, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Industrial Wellness Services Of Kentucky Pllc | 3577781582 | 3 |
News Archive
Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.
Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
› Verified 3 days ago
| Entity Name | Commonwealth Pain Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306280177 PECOS PAC ID: 0941441919 Enrollment ID: O20130802000577 |
News Archive
Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.
Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
› Verified 3 days ago
| Entity Name | Industrial Wellness Services Of Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851618607 PECOS PAC ID: 3577781582 Enrollment ID: O20140903001931 |
News Archive
Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.
Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
› Verified 3 days ago
| Entity Name | Hope Primary & Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134606403 PECOS PAC ID: 3678818580 Enrollment ID: O20181221000407 |
News Archive
Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.
Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stephanie Marie Sumner, APRN, FNP-C Po Box 21890, Belfast, ME 04915-4115 Ph: (502) 907-0356 | Mrs Stephanie Marie Sumner, APRN, FNP-C 100 London Mountain View Dr Fl 1, London, KY 40741-6668 Ph: (859) 275-5229 |
News Archive
Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.
Not all patients feel the same way about medical treatment. Some are "minimizers," preferring to see a doctor as little as possible and to give health issues a chance to resolve on their own. Others are "maximizers" who want to treat a disease to the fullest extent possible, even if doesn't make a big difference in the overall outcome.
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
› Verified 3 days ago
Robin R House, APRN NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1406 W 5th St, Suite 201, London, KY 40741 Phone: 606-330-2377 Fax: 606-330-2369 | |
Mrs. Angela Jo Cain, APRN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1374 Highway 192 E Ste 400, London, KY 40741 Phone: 606-770-5454 Fax: 606-770-5455 | |
Yalanda Dairlene Scalf, APRN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 73 Thompson Poynter Rd Ste A, London, KY 40741 Phone: 606-657-5912 Fax: 606-657-5915 | |
David Cody Dugger, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 | |
Kyra N Gambrel, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 West 5th Street, London, KY 40741 Phone: 606-864-4040 Fax: 606-864-3500 | |
Lisa Abner, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 103 Chera Lynn St, London, KY 40741 Phone: 606-864-4764 Fax: 606-864-3732 |